大葉大學圖書館 |

登入

回首頁

Biopharmaceuticals :challenges and o...

Behera, Basanta Kumara.

Biopharmaceuticals :challenges and opportunities /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615.7
書名/作者:	Biopharmaceuticals : : challenges and opportunities // Basanta Kumara Behera.
作者:	Behera, Basanta Kumara.
出版者:	Boca Raton : : CRC Press,, 2021.
面頁冊數:	xv, 278 p. : : ill. ;; 24 cm.
標題:	Biological Products - Congresses.
標題:	Biopharmaceutics
標題:	Drug Industry - trends
ISBN:	9780815347774 (hbk.) :
書目註:	Includes bibliographical references and index.
內容註:	Biopharmaceutical : A New Confront -- Biopharmaceutical Production -- Transitioning from Pharmaceutical to Biopharmaceutical -- Biopharmaceutical from Animal cells -- Plant Biomolecules and Therapeutic -- Biosimilar -- Biopharmaceutical Supply Chain Management.
摘要、提要註:	"This book highlights how traditional microbial process technology has been upgraded for the production of biologic drugs, and evolution of manufacturing process to meet the global market demand with quality products under the guide lines of internally recognised regulatory bodies. This piece of work also carries information on how armed with deeper understanding of life threatening disease, the biopharmaceutical companies or life sciences industries have developed royal scientific heritage of understanding by developing formal and informal partnerships with researchers in institute, universities and other R&D organisation to fulfil the promise of timely quality production with perfect safety and security. One of the most interesting aspects of this piece of work is the conceptual development of personalized medicine (or precision medicine) to get the right treatment to the right patient at the right dose at the earlier stage of development of any inherited disease. Besides this, it also high lights on the most challenging aspects of modern biopharmaceutical science focusing on the most burning topics like design and development of biologic drugs; use of diversified groups of host cells belonging from animals, plants, microbes, insects and mammals; stem cell therapy and gene therapy; supply chain management of biopharmaceuticals; and the future scope of biopharmaceutical industry development. This book is a latest resource for a wide circle of scientists, students and researchers involve in understanding and implementing the knowledge of biopharmaceutical to develop biologics for life saving drugs, and bring awareness on personalized medicines that can potentially offer patients faster diagnoses, fewer side effects and better outcomes. Features: Explains how the traditional cells culture methodology has been changed to fully continuous or partially continuous process. It explains how to design and fabricate living organs of body by 3D bioprinting technology

Biopharmaceuticals :challenges and opportunities /
Behera, Basanta Kumara.

Biopharmaceuticals :challenges and opportunities /Basanta Kumara Behera. - 1st ed. - Boca Raton :CRC Press,2021. - xv, 278 p. :ill. ;24 cm.

Includes bibliographical references and index.

Biopharmaceutical : A New Confront -- Biopharmaceutical Production -- Transitioning from Pharmaceutical to Biopharmaceutical -- Biopharmaceutical from Animal cells -- Plant Biomolecules and Therapeutic -- Biosimilar -- Biopharmaceutical Supply Chain Management.

"This book highlights how traditional microbial process technology has been upgraded for the production of biologic drugs, and evolution of manufacturing process to meet the global market demand with quality products under the guide lines of internally recognised regulatory bodies. This piece of work also carries information on how armed with deeper understanding of life threatening disease, the biopharmaceutical companies or life sciences industries have developed royal scientific heritage of understanding by developing formal and informal partnerships with researchers in institute, universities and other R&D organisation to fulfil the promise of timely quality production with perfect safety and security. One of the most interesting aspects of this piece of work is the conceptual development of personalized medicine (or precision medicine) to get the right treatment to the right patient at the right dose at the earlier stage of development of any inherited disease. Besides this, it also high lights on the most challenging aspects of modern biopharmaceutical science focusing on the most burning topics like design and development of biologic drugs; use of diversified groups of host cells belonging from animals, plants, microbes, insects and mammals; stem cell therapy and gene therapy; supply chain management of biopharmaceuticals; and the future scope of biopharmaceutical industry development. This book is a latest resource for a wide circle of scientists, students and researchers involve in understanding and implementing the knowledge of biopharmaceutical to develop biologics for life saving drugs, and bring awareness on personalized medicines that can potentially offer patients faster diagnoses, fewer side effects and better outcomes. Features: Explains how the traditional cells culture methodology has been changed to fully continuous or partially continuous process. It explains how to design and fabricate living organs of body by 3D bioprinting technology

ISBN: 9780815347774 (hbk.) :NTD 5,926

LCCN: 2020033145Subjects--Topical Terms:

427942
Biological Products
--Congresses.

LC Class. No.: RM301.4

Dewey Class. No.: 615.7

Biopharmaceuticals :challenges and opportunities /
LDR:03309nam a2200229 a 4500 001 509323
005 20200727070743.0
008 210521s2021 flua b 001 0 eng
010 $a 2020033145
020 $a 9780815347774 (hbk.) : $c NTD 5,926
020 $z 9781351013154 (ebook)
040 $a DNLM/DLC $b eng $c DLC $d DYU
041 0 $a eng
050 0 0 $a RM301.4
082 0 0 $a 615.7 $2 23
100 1 $a Behera, Basanta Kumara. $3 659588
245 1 0 $a Biopharmaceuticals : $b challenges and opportunities / $c Basanta Kumara Behera.
250 $a 1st ed.
260 $a Boca Raton : $b CRC Press, $c 2021.
300 $a xv, 278 p. : $b ill. ; $c 24 cm.
504 $a Includes bibliographical references and index.
505 0 $a Biopharmaceutical : A New Confront -- Biopharmaceutical Production -- Transitioning from Pharmaceutical to Biopharmaceutical -- Biopharmaceutical from Animal cells -- Plant Biomolecules and Therapeutic -- Biosimilar -- Biopharmaceutical Supply Chain Management.
520 $a "This book highlights how traditional microbial process technology has been upgraded for the production of biologic drugs, and evolution of manufacturing process to meet the global market demand with quality products under the guide lines of internally recognised regulatory bodies. This piece of work also carries information on how armed with deeper understanding of life threatening disease, the biopharmaceutical companies or life sciences industries have developed royal scientific heritage of understanding by developing formal and informal partnerships with researchers in institute, universities and other R&D organisation to fulfil the promise of timely quality production with perfect safety and security. One of the most interesting aspects of this piece of work is the conceptual development of personalized medicine (or precision medicine) to get the right treatment to the right patient at the right dose at the earlier stage of development of any inherited disease. Besides this, it also high lights on the most challenging aspects of modern biopharmaceutical science focusing on the most burning topics like design and development of biologic drugs; use of diversified groups of host cells belonging from animals, plants, microbes, insects and mammals; stem cell therapy and gene therapy; supply chain management of biopharmaceuticals; and the future scope of biopharmaceutical industry development. This book is a latest resource for a wide circle of scientists, students and researchers involve in understanding and implementing the knowledge of biopharmaceutical to develop biologics for life saving drugs, and bring awareness on personalized medicines that can potentially offer patients faster diagnoses, fewer side effects and better outcomes. Features: Explains how the traditional cells culture methodology has been changed to fully continuous or partially continuous process. It explains how to design and fabricate living organs of body by 3D bioprinting technology
520 $a It focuses on how a biopharmaceutical company confront with various problems of regulatory bodies, and develop innovative biologic drugs. It narrates in detail the update information on stem cell therapy and gene therapy. It explains the development strategies and clinical significance of bio-similars and bio-betters. It high lights on supply chain management of biopharmaceuticals"-- $c Provided by publisher.
650 1 2 $a Biological Products $v Congresses. $3 427942
650 2 2 $a Biopharmaceutics $3 729322
650 2 2 $a Drug Industry $x trends $3 729323